Ultra-trace determination of oxaliplatin impurities by sweeping-MEKC-ICP-MS

Abstract

Oxaliplatin represents a platinum-based cancerostatic drug that is widely used for the treatment of various types of cancer. There are two main platinum-containing impurities, impurity B and C, that can be formed as side products at very low concentrations. Their effect on biological systems can be like the oxaliplatin itself; however, this has not been fully investigated since there is a lack of methods for their determination in ultralow concentrations. In our work, we present a method for ultra-trace determination of oxaliplatin impurities B and C, and oxaliplatin itself, using online sweeping preconcentration micellar electrokinetic chromatography coupled with inductively coupled plasma mass spectrometry (MEKC-ICP-MS). This is the first application of online preconcentration with MEKC-ICP-MS to improve the detection limits of analytes. Under the optimal conditions, 25 mM sodium phosphate buffer at pH 2.15 with 175 mM SDS, and an injection time of 90 s at 50 mbar, baseline separation of all components within 6 min was achieved. The sweeping-MEKC-ICP-MS method was fully validated in terms of linearity, limits of detection and quantification, trueness, precision, and reproducibility of migration times. Limits of detection of 2, 1, and 3 ng mL−1 for impurity B, impurity C, and oxaliplatin, respectively, were obtained, which are 3,500-, 1,700-, and 2,100-fold lower than those for a MEKC-UV method also developed and validated as a part of this work. It also represents the detection of 98 femtograms of the impurity C (or 227 attomol of Pt) per injection. The sweeping-MEKC-ICP-MS method further benefits from a wide dynamic range up to six orders of magnitude (0.01–1,000 µg mL−1 for oxaliplatin) with coefficients of determination greater than 0.9989. ICP-MS provides characteristic element/isotope-specific and structure-independent detection. ICP-MS helped identify the co-separated impurity B counter-ion that can be wrongly assigned as the platinum-based impurity B using standard UV detection. Finally, the validated sweeping-MEKC-ICP-MS method was applied to the analysis of oxaliplatin samples with variable impurities concentrations (0.06–1.0%). The trueness and precision ranged between 76 and 115% and 2–19%, respectively. This method allows the accurate determination of oxaliplatin impurities from 0.0003% levels; therefore, it could be used in routine pharmaceutical laboratories for quality control purposes.